Robin R Ingalls, MD | |
725 Albany St, Shapiro 9, Suite B, Boston, MA 02118-2526 | |
(617) 414-4290 | |
(617) 414-4285 |
Full Name | Robin R Ingalls |
---|---|
Gender | Female |
Speciality | Infectious Disease |
Experience | 35 Years |
Location | 725 Albany St, Boston, Massachusetts |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073590808 | NPI | - | NPPES |
110056658A | Medicaid | MA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RI0200X | Internal Medicine - Infectious Disease | 74894 (Massachusetts) | Primary |
207R00000X | Internal Medicine | 74894 (Massachusetts) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Boston Medical Center | Boston, MA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Evans Medical Foundation Inc | 7416946546 | 445 |
News Archive
A paper published in the January issue of the journal Nanomedicine could provide the foundation for a new ovarian cancer treatment option - one that would use an outside-the-body filtration device to remove a large portion of the free-floating cancer cells that often create secondary tumors.
Astellas Pharma US, Inc., a U.S. subsidiary of Tokyo-based Astellas Pharma Inc., today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration seeking approval for tacrolimus extended release capsules for the prophylaxis of organ rejection in adult kidney transplant recipients and adult male liver transplant recipients.
University of Florida researchers say primitive cells that act like molecular maintenance men - traveling throughout the body to repair damaged blood vessels - become too rigid to move in patients with diabetes, fueling the disease's vascular complications.
CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, today announced the first three implantations of the CryoPatch((R)) SG pulmonary human cardiac patch since FDA clearance.
› Verified 1 days ago
Entity Name | Evans Medical Foundation Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1912954124 PECOS PAC ID: 7416946546 Enrollment ID: O20040512000397 |
News Archive
A paper published in the January issue of the journal Nanomedicine could provide the foundation for a new ovarian cancer treatment option - one that would use an outside-the-body filtration device to remove a large portion of the free-floating cancer cells that often create secondary tumors.
Astellas Pharma US, Inc., a U.S. subsidiary of Tokyo-based Astellas Pharma Inc., today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration seeking approval for tacrolimus extended release capsules for the prophylaxis of organ rejection in adult kidney transplant recipients and adult male liver transplant recipients.
University of Florida researchers say primitive cells that act like molecular maintenance men - traveling throughout the body to repair damaged blood vessels - become too rigid to move in patients with diabetes, fueling the disease's vascular complications.
CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, today announced the first three implantations of the CryoPatch((R)) SG pulmonary human cardiac patch since FDA clearance.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Robin R Ingalls, MD 720 Harrison Ave, Dob 503, Boston, MA 02118-2371 Ph: () - | Robin R Ingalls, MD 725 Albany St, Shapiro 9, Suite B, Boston, MA 02118-2526 Ph: (617) 414-4290 |
News Archive
A paper published in the January issue of the journal Nanomedicine could provide the foundation for a new ovarian cancer treatment option - one that would use an outside-the-body filtration device to remove a large portion of the free-floating cancer cells that often create secondary tumors.
Astellas Pharma US, Inc., a U.S. subsidiary of Tokyo-based Astellas Pharma Inc., today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration seeking approval for tacrolimus extended release capsules for the prophylaxis of organ rejection in adult kidney transplant recipients and adult male liver transplant recipients.
University of Florida researchers say primitive cells that act like molecular maintenance men - traveling throughout the body to repair damaged blood vessels - become too rigid to move in patients with diabetes, fueling the disease's vascular complications.
CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, today announced the first three implantations of the CryoPatch((R)) SG pulmonary human cardiac patch since FDA clearance.
› Verified 1 days ago
Kaitlyn My-tu Lam, MBBS Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-724-7738 | |
Kui Toh Gerard Leong, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 55 Fruit Street, Massachusetts General Hospital, Boston, MA 02114 Phone: 617-726-8862 | |
Ruma Rajbhandari, Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 75 Francis St, Boston, MA 02115 Phone: 617-525-6841 | |
Alaka Ray, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-726-2066 | |
Meghan E Sise, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-726-2862 | |
Aaron Dickstein, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 800 Washington St, Box 233, Boston, MA 02111 Phone: 617-636-5883 Fax: 617-636-9292 | |
Dr. Felicia Elizabeth Patch, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 801 Massachusetts Ave, Crosstown 2, Boston, MA 02118 Phone: 617-414-4376 Fax: 617-414-4676 |